Michele Abate1, Sandra Verna2, Cosima Schiavone3, Patrizia Di Gregorio2, Vincenzo Salini3. 1. Department of Medicine and Science of Aging, University G. d'Annunzio, Chieti-Pescara, Via dei Vestini 31, 66013, Chieti Scalo, CH, Italy. m.abate@unich.it. 2. Immunohaematology and Transfusional Medicine Service, "SS. Annunziata" Hospital, Chieti Scalo, CH, Italy. 3. Department of Medicine and Science of Aging, University G. d'Annunzio, Chieti-Pescara, Via dei Vestini 31, 66013, Chieti Scalo, CH, Italy.
Abstract
BACKGROUND: The combined use of hyaluronic acid and platelet-rich plasma has never been reported in the treatment for osteoarthritis. Aim of this paper was to evaluate the efficacy of this association and to compare retrospectively these results with those of a cohort of patients treated with platelet-rich plasma only. MATERIALS AND METHODS: Subjects with mild-to-moderate knee osteoarthritis were enrolled. After clinical and ultrasound evaluation, patients received a weekly intra-articular injection of 2 ml of hyaluronic acid added with 2 ml of platelet-rich plasma for 3 weeks. Follow-up was performed at 1, 3, and 6 months. The same clinical parameters were retrospectively collected from a cohort of patients treated with 4-5 ml of platelet-rich plasma only. RESULTS: Forty knees were treated in both groups. The intra-group comparison showed a significant improvement in clinical and functional outcomes at 1, 3, and 6 months, while the infra-group comparison did not show any significant difference. CONCLUSIONS: The association of platelet-rich plasma + hyaluronic acid has the same efficacy of platelet-rich plasma only, administered in higher volume. We may infer that hyaluronic acid works synergically and improves the activity of several molecules contained in platelet-rich plasma.
BACKGROUND: The combined use of hyaluronic acid and platelet-rich plasma has never been reported in the treatment for osteoarthritis. Aim of this paper was to evaluate the efficacy of this association and to compare retrospectively these results with those of a cohort of patients treated with platelet-rich plasma only. MATERIALS AND METHODS: Subjects with mild-to-moderate knee osteoarthritis were enrolled. After clinical and ultrasound evaluation, patients received a weekly intra-articular injection of 2 ml of hyaluronic acid added with 2 ml of platelet-rich plasma for 3 weeks. Follow-up was performed at 1, 3, and 6 months. The same clinical parameters were retrospectively collected from a cohort of patients treated with 4-5 ml of platelet-rich plasma only. RESULTS: Forty knees were treated in both groups. The intra-group comparison showed a significant improvement in clinical and functional outcomes at 1, 3, and 6 months, while the infra-group comparison did not show any significant difference. CONCLUSIONS: The association of platelet-rich plasma + hyaluronic acid has the same efficacy of platelet-rich plasma only, administered in higher volume. We may infer that hyaluronic acid works synergically and improves the activity of several molecules contained in platelet-rich plasma.
Authors: Javier Ramos-Torrecillas; Olga García-Martínez; Elvira De Luna-Bertos; Francisco Manuel Ocaña-Peinado; Concepción Ruiz Journal: Biol Res Nurs Date: 2014-05-20 Impact factor: 2.522
Authors: E Anitua; M Sanchez; M De la Fuente; M M Zalduendo; G Orive Journal: Knee Surg Sports Traumatol Arthrosc Date: 2011-10-11 Impact factor: 4.342
Authors: Emily A Sundman; Brian J Cole; Vasili Karas; Craig Della Valle; Mathew W Tetreault; Hussni O Mohammed; Lisa A Fortier Journal: Am J Sports Med Date: 2013-11-05 Impact factor: 6.202
Authors: Giuseppe Musumeci; Paola Castrogiovanni; Rosalia Leonardi; Francesca Maria Trovato; Marta Anna Szychlinska; Angelo Di Giunta; Carla Loreto; Sergio Castorina Journal: World J Orthop Date: 2014-04-18